_edited_edited_edited.png)
_edited_edited_edited.png)
DORSAL ROOT GANGLION THERAPY
_edited_edited_edited.png)
_edited_edited_edited.png)
Neurostimulation Therapy
-
Spinal cord stimulation (SCS) is a well-established therapy, recommended by doctors for more than 50 years
-
Worldwide, approximately 34,000 patients undergo SCS each year
-
Uses mild electrical pulses to change pain signals as they travel from the spinal cord to the brain
-
May help to reduce pain to a manageable level and to return to a more normal lifestyle
A Different Approach: Stimulating The DRG
1) Everyone has clusters of nerve cells along their spine called Dorsal Root Ganglion (DRG)
2) DRG nerves control pain signals from specific areas of the body where someone experiences pain
3) DRG therapy is a form of neurostimulation where the mild electrical signals target specific DRGs that are involved in a person’s localized pain.
4) DRG therapy is designed to target difficult-to-treat chronic pain in specific areas of the lower body – such as the pelvis, groin, hip, knee, ankle, and foot – in adult patients with CRPS and causalgia
5) Proclaim™ DRG Therapy has the unique ability to help manage chronic pain in targeted parts of
the lower extremities due to CRPS and causalgia.
Proven To Provide Superior And Long-Term Pain Relief
Abbott's DRG Therapy
-
Has been proven safe and effective in the largest neurostimulation trial for the treatment of CRPS and causalgia
-
Has been studied in over 18 studies over 7 year
-
Can be trialed before committing to another surgery
-
Eliminates the tingling sensation felt with traditional neurostimulation12
Reduce Pain
An Average Of
Provides Persistent
Pain Relief To
81.4%
86%
Of
Patients
At 12 Months
At 12 Months
Designed To Treat Patients Who Suffer From CRPS And Causalgia
The ONLY FDA Approved
DRG Technology
Approved to treat CRPS and causalgia
of the lower extremities
STEPS TO GETTING PROCLAIM™ DRG THERAPY
Step 1)
Evaluation By A Pain Management Specialist
Talk To Your Pain Management Specialist Today
-
Your doctor will determine whether you are a candidate for Proclaim DRG Therapy
-
Your Abbott representative can help answer any additional questions
Step 2)
Try It First
-
The typical evaluation period is five to seven days
-
During the trial, you can see how well the therapy controls your pain before committing to an implanted system
During the trial, you can access whether the therapy:
-
Provides meaningful pain relief
-
Improves your ability to perform daily activities
-
Improves your sleeping habits
The Invisible Trial System
Temporary Leads
Thin wires that deliver
low-energy electrical pulses
from the battery to interrupt
your pain signals
External Battery
Leads are connected to a
small external battery, worn
outside of the body, typically
on your lower back
Patient Controller
A handheld device similar to
a remote control that
enables you to adjust the
therapy
A Life-Changing First Step
-
A short procedure will be performed at your doctor’s office, a hospital or a day surgery center
-
Your doctor will place temporary leads and connect them to a small external battery
-
Your Abbott representative will program your system under your doctor’s guidance
Step 3)
Implanted System
Moving Forward With The Implanted System
-
The Proclaim™ DRG Therapy will be implanted in a surgical procedure, usually on an outpatient basis
-
The three basic components of the implanted system are similar to the temporary system
-
You and your doctor should review any possible complications or restrictions
-
Certain activities can cause the lead or leads to move and cause an unwanted change in stimulation
-
In general, you should be able to perform your daily activities with less pain over time
PLEASE NOTE: While neurostimulation helps most patients with some reduction in
pain, not everyone responds in the same way. The amount of pain relief depends
on each individual. Complications caused by placement and/or use of the device
may occur. Be sure to discuss the risks and benefits of neurostimulation with your
doctor.